PURPOSE: To characterize the ocular phenotype resulting from mutation of Rab38, a candidate gene for Hermansky-Pudlak syndrome. METHODS: Chocolate mice (cht, Rab38(cht/cht)) and control heterozygous (Rab38(cht/)(+)) and wild-type mice were examined clinically, histologically, ultrastructurally, and electrophysiologically. Mice homozygous for both the Rab38(cht) and the Tyrp1(b) alleles were similarly examined. RESULTS: Rab38(cht/cht) mice showed variable peripheral iris transillumination defects at 2 months of age. Patches of RPE hypopigmentation were noted clinically in 57% of Rab38(cht/cht) eyes and 6% of Rab38(cht/)(+) eyes. Rab38(cht/cht) mice exhibited thinning of the iris and RPE and larger b-wave amplitudes in the scotopic range when compared with the control animals. Compared with wild-type mice, Rab38(cht/cht) melanosomes were smaller and there were fewer in neuroectodermally derived retinal pigment epithelium; in neural crest-derived choroid melanocytes, they were smaller in size only. Mutation of both Rab38 and Tyrp1 produced mice with ocular and coat color pigment dilution greater than that seen with either mutation alone. Comprehensive clinical and pathologic analyses showed no other organ system or blood defects in Rab38(cht/cht) mice. CONCLUSIONS: Rab38(cht/cht) mice show ocular characteristics reminiscent of human oculocutaneous albinism, as well as iris and RPE thinning. The synergistic effects of the Rab38(cht) and Tyrp1(b) alleles suggest that TYRP1 is not the only target of RAB38 trafficking. This mouse line provides a useful model for studying melanosome biology and its role in human ocular diseases.
PURPOSE: To characterize the ocular phenotype resulting from mutation of Rab38, a candidate gene for Hermansky-Pudlak syndrome. METHODS:Chocolatemice (cht, Rab38(cht/cht)) and control heterozygous (Rab38(cht/)(+)) and wild-type mice were examined clinically, histologically, ultrastructurally, and electrophysiologically. Mice homozygous for both the Rab38(cht) and the Tyrp1(b) alleles were similarly examined. RESULTS:Rab38(cht/cht) mice showed variable peripheral iris transillumination defects at 2 months of age. Patches of RPE hypopigmentation were noted clinically in 57% of Rab38(cht/cht) eyes and 6% of Rab38(cht/)(+) eyes. Rab38(cht/cht) mice exhibited thinning of the iris and RPE and larger b-wave amplitudes in the scotopic range when compared with the control animals. Compared with wild-type mice, Rab38(cht/cht) melanosomes were smaller and there were fewer in neuroectodermally derived retinal pigment epithelium; in neural crest-derived choroid melanocytes, they were smaller in size only. Mutation of both Rab38 and Tyrp1 produced mice with ocular and coat color pigment dilution greater than that seen with either mutation alone. Comprehensive clinical and pathologic analyses showed no other organ system or blood defects in Rab38(cht/cht) mice. CONCLUSIONS:Rab38(cht/cht) mice show ocular characteristics reminiscent of human oculocutaneous albinism, as well as iris and RPE thinning. The synergistic effects of the Rab38(cht) and Tyrp1(b) alleles suggest that TYRP1 is not the only target of RAB38 trafficking. This mouse line provides a useful model for studying melanosome biology and its role in humanocular diseases.
Authors: R E Boissy; H Zhao; W S Oetting; L M Austin; S C Wildenberg; Y L Boissy; Y Zhao; R A Sturm; V J Hearing; R A King; J J Nordlund Journal: Am J Hum Genet Date: 1996-06 Impact factor: 11.025
Authors: B Chang; R S Smith; N L Hawes; M G Anderson; A Zabaleta; O Savinova; T H Roderick; J R Heckenlively; M T Davisson; S W John Journal: Nat Genet Date: 1999-04 Impact factor: 38.330
Authors: C Jiménez-Cervantes; F Solano; T Kobayashi; K Urabe; V J Hearing; J A Lozano; J C García-Borrón Journal: J Biol Chem Date: 1994-07-08 Impact factor: 5.157
Authors: Melanie Meyer; Oskar Ortiz; Martin Hrabé de Angelis; Wolfgang Wurst; Ralf Kühn Journal: Proc Natl Acad Sci U S A Date: 2012-06-01 Impact factor: 11.205
Authors: Jarred J Bultema; Judith A Boyle; Parker B Malenke; Faye E Martin; Esteban C Dell'Angelica; Richard E Cheney; Santiago M Di Pietro Journal: J Biol Chem Date: 2014-10-16 Impact factor: 5.157
Authors: Monika Köhnke; Christine Delon; Marcus L Hastie; Uyen T T Nguyen; Yao-Wen Wu; Herbert Waldmann; Roger S Goody; Jeffrey J Gorman; Kirill Alexandrov Journal: PLoS One Date: 2013-12-16 Impact factor: 3.240
Authors: Megan K Dennis; Cédric Delevoye; Amanda Acosta-Ruiz; Ilse Hurbain; Maryse Romao; Geoffrey G Hesketh; Philip S Goff; Elena V Sviderskaya; Dorothy C Bennett; J Paul Luzio; Thierry Galli; David J Owen; Graça Raposo; Michael S Marks Journal: J Cell Biol Date: 2016-08-01 Impact factor: 10.539
Authors: Anne K Hollmann; Martina Bleyer; Andrea Tipold; Jasmin N Neßler; Wilhelm E Wemheuer; Ekkehard Schütz; Bertram Brenig Journal: BMC Genet Date: 2017-03-29 Impact factor: 2.797
Authors: Michael G Anderson; Norman L Hawes; Colleen M Trantow; Bo Chang; Simon W M John Journal: Pigment Cell Melanoma Res Date: 2007-06-28 Impact factor: 4.693
Authors: Shankar Swaminathan; Hong Lu; Robert W Williams; Lu Lu; Monica M Jablonski Journal: Pigment Cell Melanoma Res Date: 2013-05-13 Impact factor: 4.693